Eli Lilly stock rose Thursday after the drugmaker easily topped third-quarter forecasts on the back of its two biggest drugs.
Pharmaceutical behemoth Eli Lilly (LLY) smashed Wall Street's third-quarter expectations and raised its full-year outlook Thursday, thanks to its diabetes and obesity treatments.
"Arguably the strongest print across 3Q so far," Cantor analyst Carter ... [3390 chars]